Skip to main content
SpringerLink
Log in

Inflammatory Bowel Disease: Ulcerative Colitis

  • Chapter
  • First Online:
Coloproctology

Part of the book series: European Manual of Medicine ((EUROMANUAL))

Abstract

Ulcerative colitis is a chronic, relapsing idiopathic inflammation of the rectum and variable lengths of the adjoining colon. Onset usually occurs during the third and fourth decades of life and commonly presents with bloody diarrhea. A diagnosis is made using a combination of endoscopic and histological evidence to distinguish it from other inflammatory colitides, in particular Crohn’s disease. The extent of the disease in terms of the amount of colon involved and the severity of the attacks both vary, and treatment is tailored depending on both these factors. Ulcerative colitis predisposes individuals to colorectal cancer, and surveillance is required for most sufferers. Acute severe colitis is the most serious manifestation of the disease and initially requires hospital treatment with intravenous steroids. Emergency surgery in the form of a subtotal colectomy and end ileostomy is vital in those not responding to medical treatment to avoid colonic perforation. There are two major elective procedures: restorative proctocolectomy (ileoanal pouch procedure) and panproctocolectomy. Laparoscopic surgery is now an option for both emergency and elective procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504–17.

    Article  PubMed  Google Scholar 

  2. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39(5):690–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ardizzone S, Bianchi Porro G. Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med. 2002;252(6):475–96.

    Article  CAS  PubMed  Google Scholar 

  4. Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis. 2004;10(6):848–59.

    Article  PubMed  Google Scholar 

  5. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med. 2001;344(11):808–14.

    Article  CAS  PubMed  Google Scholar 

  6. Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis. 2008;14:968.

    Article  PubMed  Google Scholar 

  7. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124(7):1767–73.

    Article  PubMed  Google Scholar 

  8. Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34(4):517–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet. 1996;347(9010):1212–7.

    Article  CAS  PubMed  Google Scholar 

  10. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3(7):521–33.

    Article  CAS  PubMed  Google Scholar 

  11. Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology. 2007;133(4):1327–39.

    Article  CAS  PubMed  Google Scholar 

  12. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Chambers WM, Warren BF, Jewell DP, Mortensen NJ. Cancer surveillance in ulcerative colitis. Br J Surg. 2005;92(8):928–36.

    Article  CAS  PubMed  Google Scholar 

  14. Oresland T, Bemelman WA, Sampietro GM, Spinelli A, Windsor A, Ferrante M, et al. European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis. 2015;9(1):4–25.

    PubMed  Google Scholar 

  15. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571–607.

    Article  PubMed  Google Scholar 

  16. Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013;7(1):1–33.

    Article  PubMed  Google Scholar 

  17. Sheth SG, LaMont JT. Toxic megacolon. Lancet. 1998;351(9101):509–13.

    Article  CAS  PubMed  Google Scholar 

  18. Robert JR, Sachar DB, Greenstein AJ. Severe gastrointestinal hemorrhage in Crohn’s disease. Ann Surg. 1991;213(3):207–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36.

    Article  PubMed  Google Scholar 

  20. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut. 2002;51 Suppl 5:V10–2.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2(4947):1041–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Jakobovits SL, Travis SP. Management of acute severe colitis. Br Med Bull. 2005;75–76:131–44.

    PubMed  Google Scholar 

  23. Van Assche G, D’Haens G, Noman M, Vermeire S, Hiele M, Asnong K, et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology. 2003;125(4):1025–31.

    Article  PubMed  Google Scholar 

  24. Jarnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlen P, Granno C, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005;128(7):1805–11.

    Article  PubMed  Google Scholar 

  25. Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38(6):905–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis. 2012;6(10):991–1030.

    Article  PubMed  Google Scholar 

  27. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53 Suppl 5:V1–16.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353(23):2462–76.

    Article  CAS  PubMed  Google Scholar 

  29. Bolin TD, Wong S, Crouch R, Engelman JL, Riordan SM. Appendicectomy as a therapy for ulcerative proctitis. Am J Gastroenterol. 2009;104(10):2476–82.

    Article  PubMed  Google Scholar 

  30. Gardenbroek TJ, Eshuis EJ, Ponsioen CI, Ubbink DT, D’Haens GR, Bemelman WA. The effect of appendectomy on the course of ulcerative colitis: a systematic review. Colorectal Dis. 2012;14(5):545–53.

    Article  CAS  PubMed  Google Scholar 

  31. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther. 2002;16(5):909–17.

    Article  CAS  PubMed  Google Scholar 

  32. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53(1):108–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119(2):305–9.

    Article  CAS  PubMed  Google Scholar 

  34. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124(5):1202–9.

    Article  PubMed  Google Scholar 

  35. Subramanian V, Pollok RC, Kang JY, Kumar D. Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators. Br J Surg. 2006;93(7):793–9.

    Article  CAS  PubMed  Google Scholar 

  36. Richards DM, Hughes SA, Irving MH, Scott NA. Patient quality of life after successful restorative proctocolectomy is normal. Colorectal Dis. 2001;3(4):223–6.

    Article  CAS  PubMed  Google Scholar 

  37. Muir AJ, Edwards LJ, Sanders LL, Bollinger RR, Koruda MJ, Bachwich DR, et al. A prospective evaluation of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis. Am J Gastroenterol. 2001;96(5):1480–5.

    Article  CAS  PubMed  Google Scholar 

  38. Brown SR, Travis SPL, Haboubi N, Hampton J, George B. The management of acute severe colitis: position statement of the Association of Coloproctology of Great Britain & Ireland. 2007.

    Google Scholar 

  39. Brady RR, Collie MH, Ho GT, Bartolo DC, Wilson RG, Dunlop MG. Outcomes of the rectal remnant following colectomy for ulcerative colitis. Colorectal Dis. 2008;10(2):144–50.

    CAS  PubMed  Google Scholar 

  40. Trickett JP, Tilney HS, Gudgeon AM, Mellor SG, Edwards DP. Management of the rectal stump after emergency sub-total colectomy: which surgical option is associated with the lowest morbidity? Colorectal Dis. 2005;7(5):519–22.

    Article  CAS  PubMed  Google Scholar 

  41. Wojdemann M, Wettergren A, Hartvigsen A, Myrhoj T, Svendsen LB, Bulow S. Closure of rectal stump after colectomy for acute colitis. Int J Colorectal Dis. 1995;10(4):197–9.

    Article  CAS  PubMed  Google Scholar 

  42. Ng RL, Davies AH, Grace RH, Mortensen NJ. Subcutaneous rectal stump closure after emergency subtotal colectomy. Br J Surg. 1992;79(7):701–3.

    Article  CAS  PubMed  Google Scholar 

  43. Phillips RK, Ritchie JK, Hawley PR. Proctocolectomy and ileostomy for ulcerative colitis: the longer term story. J R Soc Med. 1989;82(7):386–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Nicholls J, Tekkis P. Ulcerative colitis. In: Phillips R, editor. Colorectal surgery. 3rd ed. Philadelphia: Elsevier Ltd; 2005. p. 129–62.

    Google Scholar 

  45. Ziv Y, Fazio VW, Sirimarco MT, Lavery IC, Goldblum JR, Petras RE. Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis. Dis Colon Rectum. 1994;37(12):1281–5.

    Article  CAS  PubMed  Google Scholar 

  46. Berry AR, de Campos R, Lee EC. Perineal and pelvic morbidity following perimuscular excision of the rectum for inflammatory bowel disease. Br J Surg. 1986;73(8):675–7.

    Article  CAS  PubMed  Google Scholar 

  47. Bartels SA, Gardenbroek TJ, Aarts M, Ponsioen CY, Tanis PJ, Buskens CJ, et al. Short-term morbidity and quality of life from a randomized clinical trial of close rectal dissection and total mesorectal excision in ileal pouch-anal anastomosis. Br J Surg. 2015;102(3):281–7.

    Article  CAS  PubMed  Google Scholar 

  48. Olsen KO, Joelsson M, Laurberg S, Oresland T. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg. 1999;86(4):493–5.

    Article  CAS  PubMed  Google Scholar 

  49. Bartels SA, D’Hoore A, Cuesta MA, Bensdorp AJ, Lucas C, Bemelman WA. Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg. 2012;256(6):1045–8.

    Article  PubMed  Google Scholar 

  50. Lepisto A, Sarna S, Tiitinen A, Jarvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg. 2007;94(4):478–82.

    Article  CAS  PubMed  Google Scholar 

  51. Brown CJ, Maclean AR, Cohen Z, Macrae HM, O’Connor BI, McLeod RS. Crohn’s disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure. Dis Colon Rectum. 2005;48(8):1542–9.

    Article  PubMed  Google Scholar 

  52. Tulchinsky H, Hawley PR, Nicholls J. Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg. 2003;238(2):229–34.

    PubMed  PubMed Central  Google Scholar 

  53. Melton GB, Fazio VW, Kiran RP, He J, Lavery IC, Shen B, et al. Long-term outcomes with ileal pouch-anal anastomosis and Crohn’s disease: pouch retention and implications of delayed diagnosis. Ann Surg. 2008;248(4):608–16.

    PubMed  Google Scholar 

  54. Penna C, Dozois R, Tremaine W, Sandborn W, LaRusso N, Schleck C, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38(2):234–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Choen S, Tsunoda A, Nicholls RJ. Prospective randomized trial comparing anal function after hand sewn ileoanal anastomosis with mucosectomy versus stapled ileoanal anastomosis without mucosectomy in restorative proctocolectomy. Br J Surg. 1991;78(4):430–4.

    Article  CAS  PubMed  Google Scholar 

  56. Kirat HT, Remzi FH, Kiran RP, Fazio VW. Comparison of outcomes after hand-sewn versus stapled ileal pouch-anal anastomosis in 3,109 patients. Surgery. 2009;146(4):723–9. discussion 9-30.

    Article  PubMed  Google Scholar 

  57. Nicholls RJ, Pezim ME. Restorative proctocolectomy with ileal reservoir for ulcerative colitis and familial adenomatous polyposis: a comparison of three reservoir designs. Br J Surg. 1985;72(6):470–4.

    Article  CAS  PubMed  Google Scholar 

  58. Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11(46):7227–36.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Lichtiger et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 33:1841–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Colorectal Surgery, Royal Berkshire Hospital, Reading, RG1 5AN, UK

    P. J. Conaghan

  2. Department of Colorectal Surgery, Oxford University Hospitals, Churchill Hospital, Headington, Oxford, OX3 7LE, UK

    N. J. Mc C. Mortensen

Authors
  1. P. J. Conaghan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. J. Mc C. Mortensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. J. Conaghan .

Editor information

Editors and Affiliations

  1. End- und Dickdarm-Zentrum Mannheim, Mannheim, Germany

    Alexander Herold

  2. Clinique de chirurgie digestive et endocrinienne, Institut des maladies de l’appareil digestif, Hotel Dieu, Nantes, France

    Paul-Antoine Lehur

  3. Chirurgische Klinik mit Poliklinik, Universitaet Erlangen, Erlangen, Germany

    Klaus E. Matzel

  4. UCD School of Medicine, St Vincent’s University Hospital, Dublin, Ireland

    P. Ronan O'Connell

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Conaghan, P.J., Mortensen, N.J.M.C. (2017). Inflammatory Bowel Disease: Ulcerative Colitis. In: Herold, A., Lehur, PA., Matzel, K., O'Connell, P. (eds) Coloproctology. European Manual of Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53210-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53210-2_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53208-9

  • Online ISBN: 978-3-662-53210-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation